en

PRODUCT DETAIL

Metotrexát EVER Pharma 12,5 mg injekčný roztok v naplnenej injekčnej striekačke

Code 2493E
MA number 29/0300/22-S
Product Form: sol iru 6x0,5 ml/12,5 mg (striek.inj.skl.napl.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX03 Methotrexate
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 24.12.2022
Validity: 24.12.2027
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
PIL: PIL_Metotrexát EVER Pharma_injekčný roztok v naplnenej injekčnej striekačke_12_2022.pdf  
SPC: SPC_Metotrexát EVER Pharma_injekčný roztok v naplnenej injekčnej striekačke_12_2022.pdf  
Safety feature Yes
Data update: 03.01.2023
eu-flag.png sk-flag.png